Rabies immune globulin (human). Clinical trials and dose determination.
D000818:Animals; D000906:Antibodies / Q000032:analysis; D004372:Ducks; D006207:Half-Life; D006736:Horses; D006801:Humans; D007106:Immune Sera / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D007110:Immunity, Active; D007112:Immunity, Maternally-Acquired; D007136:Immunoglobulins / Q000627:therapeutic use; D007279:Injections, Subcutaneous; D009500:Neutralization Tests; D011818:Rabies / Q000276:immunology / Q000517:prevention & control*; D011819:Rabies Vaccines; D011820:Rabies virus / Q000276:immunology; D013997:Time Factors; D005719:gamma-Globulins / Q000627:therapeutic use*
D000906:Antibodies; D007106:Immune Sera; D007136:Immunoglobulins; D011819:Rabies Vaccines; D005719:gamma-Globulins